tm
Seeing Is Believing
tm
Seeing Is Believing
NVCT is currently covered by 1 analysts with an average price target of $39. This is a potential upside of $22.47 (64.35%) from yesterday's end of day stock price of $23.73.
Nuvectis Pharma's activity chart (see below) currently has 11 price targets and 13 ratings on display. The stock rating distribution of NVCT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 91.67% with an average time for these price targets to be met of 657 days.
Highest price target for NVCT is $39, Lowest price target is $39, average price target is $39.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 22-Jun-2026. First documented stock forecast 02-Mar-2022.
Currently out of the existing stock ratings of NVCT, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Mar-2022
$39
$15.27 (64.35%)
$13
What is NVCT (Nuvectis Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on NVCT (Nuvectis Pharma) with a proven track record?
Which analyst has the most public recommendations on NVCT (Nuvectis Pharma)?
Which analyst is the currently most bullish on NVCT (Nuvectis Pharma)?
Which analyst is the currently most reserved on NVCT (Nuvectis Pharma)?
